Atlas Trials

Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica

Clinical trial NCT05828212 · COMPLETED

Trial details

NCT number
NCT05828212
Sponsor
Zhejiang University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuromyelitis Optica
Start date
2023-05-15
Primary completion
2025-07-30
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.